Gross Margin
-7.26%vs Specialty Chemicals peers Updated Sep 20, 2026Profit Margin
-20.37%vs Specialty Chemicals peers Updated Sep 20, 2026Operating Margin
-22.92%vs Specialty Chemicals peers Updated Sep 20, 2026Return on Assets (TTM)
-5.10%vs Specialty Chemicals peers Updated Sep 20, 2026Return on Equity (TTM)
-15.75%vs Specialty Chemicals peers Updated Sep 20, 2026Revenue (TTM)
3.94BCNY587.55M · vs all stocks (USD) Updated Sep 20, 2026Revenue per Share (TTM)
2.81CNYUpdated Sep 20, 2026Quarterly Revenue Growth
-23.70%vs Specialty Chemicals peers Updated Sep 20, 2026Gross Profit (TTM)
-294.07MCNY-43.88M · vs all stocks (USD) Updated Sep 20, 2026EBITDA (TTM)
27.54MCNY4.11M · vs all stocks (USD) Updated Sep 20, 2026Net Income (TTM)
-801.94MCNY-119.67M · vs all stocks (USD) Updated Sep 20, 2026Quarterly Earnings Growth (YoY)
-26.31%vs Specialty Chemicals peers Updated Sep 20, 2026Operating Cash Flow (TTM)
253.02MCNY37.76M · vs all stocks (USD) Updated Sep 20, 2026Levered Free Cash Flow (TTM)
474.92MCNY70.87M · vs all stocks (USD) Updated Sep 20, 20265-Year Average Dividend Yield
1.17%Updated Sep 20, 2026Payout Ratio
0.00%vs Specialty Chemicals peers Updated Sep 20, 2026Minority Interest (Equity)
24.66MCNYFY2025 · Dec 31, 2025Revenue
4.52BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
4.48BCNYFY2025 · Dec 31, 2025Gross Profit
42.53MCNYFY2025 · Dec 31, 2025Operating Income
-488.13MCNY-72.84M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-667.71MCNYFY2025 · Dec 31, 2025Income Tax Expense
-56.11MCNYFY2025 · Dec 31, 2025Net Income
-611.60MCNYFY2025 · Dec 31, 2025EBIT
-587.04MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
27.54MCNYFY2025 · Dec 31, 2025Research & Development
133.95MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
60.64MCNYFY2025 · Dec 31, 2025Other Operating Expenses
69.87MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
16.25MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
80.66MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.4200CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.4200CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.39BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.39BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-611.60MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
26.84MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-164.66MCNYFY2025 · Dec 31, 2025Free Cash Flow
-191.79MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
854.00MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-611.60MCNYFY2025 · Dec 31, 2025Other Non-cash Items
86.54MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
287.00MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
73.39MCNYFY2025 · Dec 31, 2025Capital Expenditures
-27.12MCNYFY2025 · Dec 31, 2025Sale of Investments
5.51MCNYFY2025 · Dec 31, 2025Other Investing Activity
-146.73KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-21.76MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.91BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-2.10BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-94.45MCNYFY2025 · Dec 31, 2025Other Financing Charges
-389.35MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-667.54MCNYFY2025 · Dec 31, 2025